Aptevo Therapeutics Inc (NASDAQ:APVO) has a beta value of 5.05 and has seen 0.72 million shares traded in the recent trading session. The APVO stock
During the last session, Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares were 1.59 million, with the beta value of the company hitting 5.05. At the end
During the last session, Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares were 12.73 million, with the beta value of the company hitting 5.02. At the end
In today’s recent session, 0.44 million shares of the Aptevo Therapeutics Inc (NASDAQ:APVO) have been traded, and its beta is 5.02. Most recently the company’s
In the last trading session, 3.89 million Aptevo Therapeutics Inc (NASDAQ:APVO) shares changed hands as the company’s beta touched 5.02. With the company’s per share
In the last trading session, 2.84 million Aptevo Therapeutics Inc (NASDAQ:APVO) shares changed hands as the company’s beta touched 5.05. With the company’s per share
In recent trading session, Aptevo Therapeutics Inc (NASDAQ:APVO) saw 4.35 million shares changing hands at last check today with its beta currently measuring 5.02. Company’s
Aptevo Therapeutics Inc (NASDAQ:APVO) has a beta value of 5.06 and has seen 2.22 million shares traded in the last trading session. The company, currently
During the last session, Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares were 1.18 million, with the beta value of the company hitting 5.14. At the end
In the last trading session, 2.19 million shares of the Aptevo Therapeutics Inc (NASDAQ:APVO) were traded, and its beta was 5.14. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
